Other

Foreign currency effect

Vertex Pharmaceuticals Foreign currency effect remained flat by 0.0% to $10.98M in Q4 2025 compared to the prior quarter.

Analysis

StatementIncome Statement
SectionOther
CategoryRisk
SignalContext dependent
VolatilityModerate
First reportedQ1 2023
Last reportedQ4 2025Feb 13, 2026

How to read this metric

An increase or decrease reflects external macroeconomic volatility rather than changes in the underlying tax strategy or risk profile.

Detailed definition

This metric captures the impact of fluctuations in foreign currency exchange rates on the valuation of unrecognized tax...

Peer comparison

Standard disclosure for multinational companies with significant cross-border tax exposures.

Metric ID: other_unrecognized_tax_benefits_increases_resulting_from_0e6d84

Historical Data

2 years
 FY'23FY'25
Value$300.00K$43.90M
YoY Change>999%
Range$300.00K$43.90M
Avg YoY Growth>999%
Median YoY Growth>999%

Frequently Asked Questions

What is Vertex Pharmaceuticals's foreign currency effect?
Vertex Pharmaceuticals (VRTX) reported foreign currency effect of $10.98M in Q4 2025.
What does foreign currency effect mean?
The change in tax liability value caused by foreign currency exchange rate movements.